The Role of Alginate Hydrogels as a Potential Treatment Modality for Spinal Cord Injury: A Comprehensive Review of the Literature

• Published in: Neurospine
• Main Authors: Ryan Jarrah, Sally El Sammak, Chiduziem Onyedimma, Abdul Karim Ghaith, F.M. Moinuddin, Archis R. Bhandarkar, Ahad Siddiqui, Nicolas Madigan, Mohamad Bydon
• Format: Article
• Language: English
• Published: Korean Spinal Neurosurgery Society 2022-06-01
• Subjects: spinal cord injury; alginate hydrogel; biomaterial; tissue regeneration
• Online Access: http://e-neurospine.org/upload/pdf/ns-2244186-093.pdf
• ISSN: 2586-6583; 2586-6591

Objective To comprehensively characterize the utilization of alginate hydrogels as an alternative treatment modality for spinal cord injury (SCI). Methods An extensive review of the published literature on studies using alginate hydrogels to treat SCI was performed. The review of the literature was performed using electronic databases such as PubMed, EMBASE, and OVID MEDLINE electronic databases. The keywords used were “alginate,” “spinal cord injury,” “biomaterial,” and “hydrogel.” Results In the literature, we identified a total of 555 rat models that were treated with alginate scaffolds for regenerative biomarkers. Alginate hydrogels were found to be efficient and promising substrates for tissue engineering, drug delivery, neural regeneration, and cellbased therapies for SCI repair. With its ability to act as a pro-regenerative and antidegenerative agent, the alginate hydrogel has the potential to improve clinical outcomes. Conclusion The emerging developments of alginate hydrogels as treatment modalities may support current and future tissue regenerative strategies for SCI.